Weight loss drug market in emerging nations to hit $22B

JP Morgan estimates the weight loss drug market in China India and Brazil will grow to $22 billion by 2035. Improved affordability and rising demand will drive this expansion.

Xurve View
Insights:
FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weigh loss, are placed on a table for a photograph in a health clinic in Hyderabad, India, April 14, 2025.

The combined weight-loss drug market across China, India, and Brazil will expand to $22 billion by 2035 from $6.6 billion, J.P. Morgan projected on Friday morning.

IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.